Aberger, S; Schuller, M; Artinger, K; Mooslechner, AA; Gashi, A; Pfeifer, V; Prietl, B; Kirsch, AH; Rosenkranz, A; Eller, K
Biologic effect evaluation of de novo long-term release tacrolimus on metabolizer phenotype and T cell composition after kidney transplantation
NEPHROL DIAL TRANSPL. 2024; 39: I2673-I2673.-61st Congress of European-Renal-Association (ERA); MAY 23-26, 2024; Stockholm, SWEDEN.
[Oral Communication]
Web of Science
Aberger, S; Schuller, M; Artinger, K; Mooslechner, AA; Gashi, A; Pfeifer, V; Prietl, B; Kirsch, AH; Rosenkranz, A; Eller, K
Biologic effect evaluation of de novo long-term release tacrolimus on metabolizer phenotype and T cell composition after kidney transplantation
NEPHROL DIAL TRANSPL. 2024; 39: -61st ERA Congress; MAY 23-26, 2024; Stockholm, SWEDEN.
Doi: 10.1093/ndt/gfae069.1689
[Poster]
Web of Science
FullText
FullText_MUG
Kloetzer, KA; Abedini, A; Balzer, MS; Liang, XJ; Levinsohn, J; Ha, EJ; Schuller, M; Dumoulin, B; Hogan, J; Eller, K; Bloom, RD; Zhang, N; Susztak, K
Advancing Precision Medicine with scSpectra: Single-Cell Functional Profiling of Individual Patients with Kidney Diseases
J AM SOC NEPHROL. 2024; 35(10):
Doi: 10.1681/ASN.2024rks5hmc3
Web of Science
FullText
FullText_MUG
Klötzer, KA; Abedini, A; Balzer, MS; Liang, X; Levinsohn, J; Ha, E; Schuller, M; Dumoulin, B; Hogan, J; Eller, K; Bloom, RD; Zhang, N; Susztak, K
Advancing Precision Medicine with scSpectra: Single-Cell Functional Profiling of Individual Patients with Kidney Diseases
ASN Kidney Week 2024; OKT 24–27, 2024; San Diego, USA. 2024.
[Oral Communication]
Klötzer, KA; Göhring, S; Schuller, M; Mooslechner, A; Schabhüttl, C; Habisch, H; Bourgeois, B; Pollheimer, M; Krall, M; Madl, T; Eller, P; Rosenkranz, A; Artinger, K; Eller, K
Multi-Omics Analysis of the Cellular Adaptations to a Ketogenic Diet in the Diseased Kidney: Understanding Opportunities and Risks at Single-Cell Resolution.
Jahrestagung der ÖGN und ÖGH.; OKT 3-5, 2024; Graz, AUSTRIA. 2024.
[Poster]
Schuller, M; Aigner, C; Pollheimer, MJ; Rosenkranz, AR; Eller, K
Rebound Albuminuria after Discontinuation of Eculizumab in Three Cases of Idiopathic Membranoproliferative Glomerulonephritis
J AM SOC NEPHROL. 2024; 35(10):
Doi: 10.1681/ASN.2024xwqkn119
Web of Science
FullText
FullText_MUG
Amenitsch, JA; Kolland, M; Schuller, M; Ginthör, N; Scemez, B; Schneditz, D; Niedrist, T; Riedl, R; Eller, K; Rosenkranz, A; Kirsch, AH
Hemodynamics in chronic hemodialysis patients undergoing isolated ultrafiltration compared to conventional hemodialysis - a pilot study.
Research Retreat der klinischen Abteilung für Nephrologie; NOV 17-18, 2023; St. Nikolai im Sausal, AUSTRIA. 2023.
[Oral Communication]
Klötzer, K.; Schuller, M.; Krall, M.; Schabhüttl, C.; Mooslechner, A.; Habisch, H.; Bourgeois, B.; Madl, T.; Rosenkranz, A.; Eller, P.; Artinger, K.; Eller, K.
KETOGENIC DIET IN EXPERIMENTAL GLOMERULONEPHRITIS.
14th Biennial International Podocyte Conference. Glomerular Dis. 2023; 3(Suppl 1): 1–98.. 2023; -14th Biennial International Podocyte Conference; MAY 24-26, 2023; Philadelphia, USA.
[Poster]
Klötzer, KA; Schuller, M; Krall, M; Artinger, K; Mooslechner, A; Schabhüttl, C; Habisch, H; Bourgeois, B; Madl, T; Eller, P; Rosenkranz, A; Eller, K
Ketogene Diät lindert Nierenfibrose und führt zum partiellen Erhalt der Nierenfunktion in der nephrotoxischen Serumnephritis.
Gemeinsame Jahrestagung der ÖGN und ÖGH; SEP 28-30, 2023; Hall in Tirol. 2023.
[Poster]
Klötzer, KA; Schuller, M; Krall, M; Artinger, K; Mooslechner, A; Schabhüttl, C; Habisch, H; Bourgeois, B; Madl, T; Eller, P; Rosenkranz, A; Eller, K
Ketogene Diät verbessert die Nierenfibrose und erhält die Nierenfunktion in der nephrotoxischen Serumnephritis.
15. Jahrestagung der Deutschen Gesellschaft für Nephrologie; OKT 5-8, 2023; Berlin. 2023.
[Poster]
Klötzer, KA; Schuller, M; Krall, M; Artinger, K; Mooslechner, A; Schabhüttl, C; Habisch, H; Bourgeois, B; Madl, T; Eller, P; Rosenkranz, A; Eller, K
Ketogenic Diet Mitigates Renal Fibrosis and Preserves Kidney Function in Nephrotoxic Serum Nephritis.
ÖGIM Jahrestagung 2023; SEP 21-23, 2023; Salzburg, AUSTRIA. 2023.
[Poster]
Klötzer, KA; Schuller, M; Krall, M; Artinger, K; Schabhüttl, C; Mooslechner, AA; Habisch, H; Madl, T; Rosenkranz, AR; Eller, P; Eller, K
Ketogenic Diet Mitigates Renal Fibrosis and Partially Preserves Kidney Function in Nephrotoxic Serum Nephritis.
ASN Kidney Week 2023; NOV 2-5, 2023; Philadelphia, USA. 2023.
[Poster]
Kolland, M; Amenitsch, J; Schreiber, N; Ginthör, N; Schuller, M; Riedl, R; Rainer, P; Schneditz, D; Niedrist, T; Eller, K; Krietemeyer, B; Rosenkranz, AR; Kirsch, AH
Clearance of cardiac troponins depends on hemodialysis mode:
A randomized cross-over trial.
J Am Soc Nephrol. 2023; 34(Suppl.):888--Kidney Week 2023; NOV 1-5, 2023; Philadelphia, PA.
[Poster]
FullText
Schuller, M; Oberhuber, M; Prietl, B; Prugger, EM; Magnes, C; Zugner, E; Eller, K
Alterations of the kynurenine pathway and lipid dysregulation are preserved features of COVID-19 in hemodialysis
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 3):224-224.
[Poster]
Web of Science
Schuller, M; Oberhuber, M; Prietl, B; Zugner, E; Prugger, EM; Magnes, C; Eller, K
SAME BUT DIFFERENT? COVID-19 METABOLOME IN HEMODIALYSIS
NEPHROL DIAL TRANSPL. 2022; 37: I677-I677.
[Poster]
Web of Science
Klötzer, KA; Artinger, K; Mooslechner, A; Schuller, M; Schabhüttl, C; Eller, P; Rosenkranz, A; Eller, K;
Effekte des GLP-1-Rezeptor-Agonisten Liraglutid auf den Glukosestoffwechsel der T- Zellen.
13. Jahrestagung der Deutschen Gesellschaft für Nephrologie; Sep 23-26, 2021; Hansestadt Rostock. 2021.
[Poster]
Mooslechner, AA; Schuller, M; Artinger, K; Kirsch, AH; Schabhuttl, C; Rosenkranz, AR; Eller, K
Regulatory potential of local Ly49(+)CD8(+) memory T cell abundance in chronic kidney disease
EUR J IMMUNOL. 2021; 51: 247-247.
Web of Science